A bacterial equivalent of ACE2 (based on 3D structure rather than primary sequence) termed B38‐CAP has been described, which is reported to reduce hypertension and limit cardiac dysfunction in an animal model (Minato et al., 2020). This evidence concerns the gene ACE2 and hypertensive disorder.